← Back to all trials
Not Yet Recruiting
NCT07859514
Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of Duodenal Adenomas In Patients With Hereditary Conditions Such As FAP, HNPCC
Conditions: Prospective Study , Questionaires, Outcomes, Nitrous Oxide, Cryoablation, Duodenal Adenoma, Hereditary Conditions, FAP, HNPCC
Sex: All
Ages: 20 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: M.D. Anderson Cancer Center
Location: UT MD Anderson Cancer Center Houston Texas
Summary
To learn how well nitrous oxide cryoballoon ablation, a procedure that uses extreme cold to destroy abnormal tissue, works in treating flat duodenal adenomas (abnormal growths in the small intestine) in people with FAP or Lynch syndrome (HNPCC).
Eligibility Criteria
Eligibility Criteria
* Participants aged 20-75 years.
* Confirmed diagnosis of FAP or HNPCC.
* Presence of flat duodenal adenomas confirmed by histology.
* Ability to understand and willingness to sign an informed consent form.
Exclusion Criteria
* Presence of invasive duodenal cancer.
* Severe comorbidities that would contraindicate endoscopic procedures.
* Allergy or intolerance to components of the nitrous oxide cryoballoon system.
* Previous duodenal surgery affecting the study area.
* Active gastrointestinal bleeding. Pregnancy
Source: ClinicalTrials.gov (NCT07859514). StuddyBuddy aggregates publicly available trial information.
